Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

1

Revenue 2017

Pfizer

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Pfizer's sales performance.

Pfizer

Pfizer snaps up Biohaven’s migraine drug for $1.24bn

Pfizer snaps up Biohaven’s migraine drug for $1.24bn Pfizer will sell the migraine drug outside the US and will also gain the rights to a second drug. ... Moving forwards, Biohaven will continue to lead research and development globally and Pfizer will execute commercialisation globally, outside the US.

Pfizer's oral antiviral Paxlovid significantly cuts risk of severe COVID-19

Pfizer's oral antiviral Paxlovid significantly cuts risk of severe COVID-19 The therapy also shows 'potent antiviral in vitro activity' against variants of concern, said Pfizer. ... Pfizer has committed to 'equitable access' at an affordable price through a tiered pricing approach based on the income level of each country.

Pfizer's 2021 revenue predictions soar to $82bn

Pfizer's 2021 revenue predictions soar to $82bn Strong third-quarter revenues of $24.1bn lifted by sales of its BioNTech-partnered COVID-19 vaccine Comirnaty see Pfizer raise its 2021 revenue guidance to $82bn. ... Pfizer is having a good year. Following third-quarter sales figures that beat even the

Novartis invests $1.3bn in protein degradation technology

Novartis invests $1.3bn in protein degradation technology In July, Pfizer paid $1bn upfront to Arvinas (plus an additional $1.4bn in future milestone payments and a share of profits) for ARV-471, a breast cancer candidate currently in

Novartis receives approval for third-generation leukaemia therapy

Novartis receives approval for third-generation leukaemia therapy This indication was supported by data from the pivotal phase 3 ASCEMBL trial, where Scemblix demonstrated significant and clinically meaningful superiority over Pfizer’s second-generation treatment Bosulif (bosutinib).

[ Previous 5 results ] 7 8 9 10 11 12 13 14 15 16 [ Next 5 results ]

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Nucleus Global

Nucleus Global is the largest specialist medical communications network in the world. Globally, we have over 800 experts delivering world-class...

Latest intelligence

Why big pharma needs to be braver
The last few years have seen the pharmaceutical industry undergo a rapid metamorphosis in the face of unprecedented change, but communications are one area that still needs an injection of...
Leveraging Real-World Evidence for Cell and Gene Therapies
Regulators and reimbursement bodies are increasingly turning to real-world evidence (RWE) to understand the long-term value of drugs, in particular novel therapies. Here, Mariam Bibi, Senior Director, Global RWE at...
Food Allergy – Is avoidance the only option?
Following on from Allergy Awareness Week 2022, we’re continuing the discussion about food allergies and the experiences of those who live with them. In this blog, we discuss the current...